Powered by: Motilal Oswal
05-05-2021 09:08 AM | Source: ARETE Securities Ltd
Key News - L&T Infotech, Shriram Transport Finance Ltd, Alembic Pharma Ltd, RBL Bank, Adani Ports and Special Economic Zone Ltd by ARETE Securities
News By Tags | #1518 #1428 #3606 #3646 #1219 #572

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Key News

L&T Infotech Q4 net profit rises 28%; declares final dividend of Rs 25

L&T Infotech, the IT services arm of the L&T conglomerate, reported net profit of Rs 546 crore for the fourth quarter ended March 31, 2021, up 27.6 per cent year-on-year and was up 5 per cent sequentially. Revenue for Q4FY21 grew 8.5 per cent at Rs 3,269.4 crore on a y-o-y basis and was up 3.7 per cent q-o-q. “Supported by a strong Q4, FY21 was another year of market leading growth. In Q4, we also won two large deals with net new TCV of $66 million, culminating into a record large deal TCV for FY21. Our superior performance is a result of the untiring efforts of 35,000+ LTItes who stood together during one of the most trying times ensuring client deliveries. We will continue to invest in the strength of our business as we remain committed to growth in FY22 as well,” said Sanjay Jalona, CEO and MD, L&T Infotech.

 

Shriram Transport Finance aims 10-12% AUM growth in fiscal year 22

Non-banking finance company Shriram Transport Finance is looking at a 10-12 per cent growth in its asset under management (AUM) during fiscal 2021-22, its managing director and CEO Umesh Revankar said. The asset financing NBFC registered a 6.83 per cent growth in its AUM to Rs 117,242.83 crore as of March 31, 2021, compared to Rs 109,749.24 crore as of March 2020. "We have kept a target of 10-12 per cent growth in our AUM in FY22. We feel that there is enough pent-up demand. Even though the demand is temporarily getting postponed because of the surge in COVID-19 cases, it will come back by June, Revankar said.

 

Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses

Alembic Pharmaceuticals Limited (APL) has posted a 12 per cent growth in net profit for the quarter ended March 31, to Rs 251 crore, from Rs 225 crore during the corresponding period last year. The company's net sales were up six per cent to Rs 1,280 crore, from Rs 1,207 crore. On a full-year basis, the company's net profit rose 42 per cent to Rs 1,178 crore for FY21, from Rs 829 crore in FY20, while net sales were up 17 per cent to Rs 5,393 crore (Rs 4,606 crore)

 

RBL Bank Q4 net dives 34% as provisions on credit cards, MFI loans rise

Small-sized private lender RBL Bank on Tuesday reported a 34 per cent decline in its March quarter profit to Rs 75 crore compared to Rs 114 crore in the year-ago period due to provisioning for possible loan losses that it sees in the retail unsecured segments. The city-based lender's net profit for FY2020-21 increased marginally to Rs 508 crore from the year-ago's Rs 506 crore. Total income during the January-March quarter fell to Rs 2,611 crore from Rs 2,709 crore in the year-ago period, the bank said in a regulatory filing.

 

APSEZ Q4 PAT up by 288%; Adani Total Gas Q4 PAT up by 19%

Adani Ports and Special Economic Zone (APSEZ) Ltd. has posted a 288 per cent growth in its profit after tax (PAT) for the quarter ended March 31, 2021 at Rs 1,321 crore, up from Rs 340 crore for the corresponding period last year. For the full financial year 2020-21 (FY21) the company's PAT grew by 33 per cent to stand at Rs 5,049 crore, as against Rs 3,785 crore last year. The company's operating revenue for Q4 of FY21 grew by 24 per cent to Rs 3,608 crore, up from Rs 2,921 crore in Q4 of previous year while that for the full year increased by six per cent to Rs 12,550 crore as against Rs 11,873 crore last year. In terms of cargo, APSEZ posted a 27 per cent to handle 73 million metric tonnes (mmt) in Q4 of FY21, up from 58 mmt in Q4 of FY20. For the full year, the company's cargo volume grew by 11 per cent to 247 mmt in FY21, up from 223 mmt in FY20

 


To Read Complete Report & Disclaimer Click Here

 

Above views are of the author and not of the website kindly read disclaimer